Enhance the Use of Genetic Counseling and Testing in Latinas

Summary

The investigators will conduct a two-arm RCT to evaluate the preliminary effectiveness of a culturally-adapted video developed by the team vs. a FORCE fact sheet on enhancing genetic cancer risk assessment (GCRA; including genetic counseling and option for genetic testing) uptake and psychosocial outcomes among Latinas at increased risk for hereditary breast and ovarian cancer (HBOC).

Conditions

• Hereditary Breast and Ovarian Cancer Syndrome

Interventions

BEHAVIORAL

Culturally-Targeted Video

Culturally targeted narrative video: "Is My Cancer Hereditary? Rosa Visits a Genetic Counselor." With R03 funding (R03CA191543) we developed a culturally targeted narrative video for at-risk Latinas. A multidisciplinary team of researchers collaborated with filmmakers to develop the script and video. The script was informed by health behavior conceptual models, evidence-based risk communication strategies, and formative research (40 interviews with providers and at-risk Latinas). The script addressed identified knowledge gaps (e.g., incorrect belief that pap smears screen for ovarian cancer), facilitators (e.g., inform family cancer risk), barriers (e.g., emotional concerns), and cultural factors (e.g., respect). The 18-minute video illustrates the GCRA process with the story of Rosa, a Latina cancer survivor at increased risk of HBOC. Rosa learns about HBOC risk factors, overcomes barriers, and attends genetic counseling.

OTHER

FORCE Fact Sheet

A publically available Spanish-language fact sheet about HBOC and GCRA developed by FORCE.

Sponsors & Collaborators

• Basser Center for BRCA

  collaborator UNKNOWN

• Nueva Vida, Inc.

  collaborator INDUSTRY

• Capital Breast Care Center

  collaborator UNKNOWN

• Virginia Commonwealth University

  collaborator OTHER

• Arlington Free Clinic

  collaborator UNKNOWN

• Georgetown University

  lead OTHER

Principal Investigators

• Alejandra Hurtado de Mendoza, Ph.D · Georgetown University

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2020-02-24

Primary Completion

2022-01-31

Completion

2022-01-31

Countries

• United States

Study Locations